79 related articles for article (PubMed ID: 35948701)
1. Cervical cancer screening and predictors of screening by diabetes status.
Miller EA; Pinsky PF
Cancer Causes Control; 2022 Oct; 33(10):1305-1312. PubMed ID: 35948701
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
3. The determination of the knowledge level and behavior of Turkish women from various occupations about human papillomavirus, cervical cancer, and pap smear test.
Cimke VS; Borekci G
J Cancer Res Ther; 2019; 15(6):1235-1244. PubMed ID: 31898654
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
Katki HA; Kinney WK; Fetterman B; Lorey T; Poitras NE; Cheung L; Demuth F; Schiffman M; Wacholder S; Castle PE
Lancet Oncol; 2011 Jul; 12(7):663-72. PubMed ID: 21684207
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
6. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
[TBL] [Abstract][Full Text] [Related]
7. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
8. Pap smear recommendations in older women, does the data support stopping?
Grabinski E; Dunsmoor-Su R
Curr Opin Obstet Gynecol; 2023 Apr; 35(2):160-163. PubMed ID: 36924411
[TBL] [Abstract][Full Text] [Related]
9. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
11. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
12. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
Buick C; Jembere N; Wang L; Kupets R
J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
[TBL] [Abstract][Full Text] [Related]
13. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening among women with comorbidities: a cross-sectional examination of disparities from the Behavioral Risk Factor Surveillance System.
Austin J; Delgado P; Gatewood A; Enmeier M; Frantz B; Greiner B; Hartwell M
J Osteopath Med; 2022 Mar; 122(7):359-365. PubMed ID: 35285219
[TBL] [Abstract][Full Text] [Related]
15. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
17. [New strategies for the prevention and control of cervical cancer in Chile.].
Ferreccio C
Salud Publica Mex; 2018; 60(6):713-721. PubMed ID: 30699276
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening among young adult women in the United States.
Roland KB; Benard VB; Soman A; Breen N; Kepka D; Saraiya M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):580-8. PubMed ID: 23355601
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
Jin XW; Xu H
Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.
Praditsitthikorn N; Teerawattananon Y; Tantivess S; Limwattananon S; Riewpaiboon A; Chichareon S; Ieumwananonthachai N; Tangcharoensathien V
Pharmacoeconomics; 2011 Sep; 29(9):781-806. PubMed ID: 21838332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
